SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-017152
Filing Date
2013-03-25
Accepted
2013-03-25 12:21:14
Documents
10
Period of Report
2013-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v338719_10q.htm 10-Q 543742
2 EXHIBIT 4.1 v338719_ex4-1.htm EX-4.1 278945
3 EXHIBIT 4.2 v338719_ex4-2.htm EX-4.2 74680
4 EXHIBIT 10.3 v338719_ex10-3.htm EX-10.3 227211
5 EXHIBIT 10.4 v338719_ex10-4.htm EX-10.4 56735
6 EXHIBIT 10.5 v338719_ex10-5.htm EX-10.5 44848
7 EXHIBIT 31.1 v338719_ex31-1.htm EX-31.1 12150
8 EXHIBIT 31.2 v338719_ex31-2.htm EX-31.2 12187
9 EXHIBIT 32.1 v338719_ex32-1.htm EX-32.1 4802
10 EXHIBIT 32.2 v338719_ex32-2.htm EX-32.2 4747
  Complete submission text file 0001144204-13-017152.txt   1261210
Mailing Address TECHNOLOGY CENTRE OF NEW JERSEY 675 ROUTE 1 NORTH BRUNSWICK NJ 08902
Business Address TECHNOLOGY CENTRE OF NEW JERSEY 675 ROUTE 1 NORTH BRUNSWICK NJ 08902 732 545 1590
Advaxis, Inc. (Filer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 000-28489 | Film No.: 13713408
SIC: 2834 Pharmaceutical Preparations